Related Experiment Videos

Cytomegalovirus production by infected astrocytes correlates with transforming growth factor-beta release

Thomas Kossmann1, M Cristina Morganti-Kossmann, Jan M Orenstein

  • 1Oral Infection and Immunity Branch, National Institute of Dental and Crainofacial Research, National Institutes of Health, Bethesda, Maryland, USA.

Insights

Cytomegalovirus (CMV) encephalitis pathogenesis involves astrocytes producing transforming growth factor-beta (TGF-beta). This TGF-beta enhances CMV replication in brain cells, suggesting a key mechanism in CMV encephalitis.

Area of Science:

  • Neurovirology
  • Immunology
  • Cellular Biology

Background:

  • Cytomegalovirus (CMV) encephalitis is a known complication in immunosuppressed individuals, particularly those with acquired immunodeficiency syndrome (AIDS).
  • The precise mechanisms driving CMV encephalitis pathogenesis remain largely unexplored.
  • Initial observations linked CMV inclusions and TGF-beta to astrocytes in patient brain tissue.

Purpose of the Study:

  • To investigate the relationship between Cytomegalovirus (CMV) and transforming growth factor-beta (TGF-beta) in the context of brain infection.
  • To elucidate the role of astrocytes in CMV encephalitis pathogenesis.

Main Methods:

  • Establishment of an ex vivo murine model using primary astrocyte cultures.
  • Inoculation of murine astrocytes with murine CMV (Smith strain).
  • Quantification of infectious CMV, TGF-beta mRNA, and TGF-beta peptide levels over time.
  • Assessment of CMV release in response to TGF-beta modulation (antibody and exogenous addition).

Main Results:

  • CMV-infected astrocytes showed a time-dependent increase in both infectious CMV and TGF-beta mRNA/peptide levels.
  • Astrocyte release of CMV was inhibited by antibodies targeting TGF-beta.
  • Exogenous TGF-beta significantly enhanced CMV release from infected astrocytes.

Conclusions:

  • CMV infection in astrocytes stimulates the production of TGF-beta.
  • TGF-beta plays a crucial role in promoting productive CMV replication and release from astrocytes.
  • This interaction highlights a potential therapeutic target for managing CMV encephalitis.

Related Concept Videos